Cart
sales@molnova.com
MD 69276
CAS No. 29218-27-7
MD 69276( Toloxatone )
Catalog No. M20076 CAS No. 29218-27-7
MD 69276 (Toloxatone) is a reversible monoamine oxidase A (MAOA) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 47 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 170 | In Stock |
|
| 50MG | 294 | In Stock |
|
| 100MG | 503 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMD 69276
-
NoteResearch use only, not for human use.
-
Brief DescriptionMD 69276 (Toloxatone) is a reversible monoamine oxidase A (MAOA) inhibitor.
-
DescriptionMD 69276 (Toloxatone) is a reversible monoamine oxidase A (MAOA) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsToloxatone
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorMAO-A
-
Research AreaNeurological Disease
-
IndicationAntidepressant
Chemical Information
-
CAS Number29218-27-7
-
Formula Weight207.23
-
Molecular FormulaC11H13NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL (241.3 mM)
-
SMILESCc1cccc(c1)N1CC(CO)OC1=O
-
Chemical Name5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.FMoureau et al. A reversible monoamine oxidase inhibitor toloxatone: spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD). European Journal of Medicinal Chemistry. 1994 29(4):269-277.
molnova catalog
related products
-
hMAO-B-IN-5
hMAO-B-IN-5 is a potent reversible and selective human monoamine oxidase hMAO-B inhibitor (IC50:0.12μM).
-
Furazolidone
Furazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO transformed cells with IC50 value of 12.7 μM.
-
Selegiline hydrochlo...
Selegiline hydrochloride is a selective reversible inhibitor of MAO-B (Ki = 0.091 μM) over MAO-A (Ki = 9.06 μM). Monoamine oxidase (MAO) inhibitors have utility in ameliorating a variety of neurological conditions including depression.
